{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T20:42:34Z","timestamp":1781210554952,"version":"3.54.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T00:00:00Z","timestamp":1535500800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Kockska stiftelse Sweden"},{"name":"SUS stiftelser och donationsfonder Sweden"},{"DOI":"10.13039\/501100009800","name":"Stiftelsen Professor Nanna Svartz Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009800","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Reumatikerfonden"},{"DOI":"10.13039\/501100005390","name":"Alfred \u00d6sterlunds Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005390","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Anna Greta Crafoords stiftelse SE"},{"name":"Inger Bendix stiftelse (SE)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13075-018-1697-6","type":"journal-article","created":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T15:21:59Z","timestamp":1535556119000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["The risk of clinically diagnosed gout by serum urate levels: results from 30\u00a0years follow-up of the Malm\u00f6 Preventive Project cohort in southern Sweden"],"prefix":"10.1186","volume":"20","author":[{"given":"Meliha C.","family":"Kapetanovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Turesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Englund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Dalbeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart","family":"Jacobsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,29]]},"reference":[{"key":"1697_CR1","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/0002-9343(87)90441-4","volume":"82","author":"EW Campion","year":"1987","unstructured":"Campion EW, Glynn RJ, DeLabry LO. Asymptomatic hyperuricemia. Risks and consequences in the normative aging study. Am J Med. 1987;82:421\u20136.","journal-title":"Am J Med"},{"issue":"2","key":"1697_CR2","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1136\/ard.2004.024091","volume":"64","author":"TR Mikuls","year":"2005","unstructured":"Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Schumacher HR Jr, Saag KG. Gout epidemiology: results from the UK general practice research database 1990-1999. Ann Rheum Dis. 2005;64(2):267\u201372.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"1697_CR3","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1002\/art.30520","volume":"63","author":"Y Zhu","year":"2011","unstructured":"Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and nutrition examination survey 2007-2008. Arthritis Rheum. 2011;63(10):3136\u201341.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1697_CR4","first-page":"1045","volume":"27","author":"KC Lin","year":"2000","unstructured":"Lin KC, Lin HY, Chou P. Community based epidemiological study on hyperuricemia and gout in kin-Hu. Kinmen J Rheumatol. 2000;27(4):1045\u201350.","journal-title":"Kinmen J Rheumatol"},{"issue":"8","key":"1697_CR5","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1136\/annrheumdis-2013-204647","volume":"73","author":"E Smith","year":"2014","unstructured":"Smith E, Hoy D, Cross M, Merriman TR, Vos T, Buchbinder R, Woolf A, March L. The global burden of gout: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014;73(8):1470\u20136.","journal-title":"Ann Rheum Dis"},{"key":"1697_CR6","unstructured":"Kuo C, Grainge MJ, Zhang W, et al. Global epidemiology of gout: prevalence, incidence and risk factors. Nat Publ Gr. 2015;(Box 1):1\u201314."},{"key":"1697_CR7","first-page":"762820","volume":"2015","author":"R Liu","year":"2015","unstructured":"Liu R, Han C, Wu D, Xia X, Gu J, Guan H, Shan Z, Teng W. Prevalence of Hyperuricemia and gout in mainland China from 2000 to 2014: a systematic review and meta-analysis. Biomed Res Int. 2015;2015:762820.","journal-title":"Biomed Res Int"},{"key":"1697_CR8","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s10067-014-2520-7","volume":"33","author":"H Duskin-Bitan","year":"2014","unstructured":"Duskin-Bitan H, Cohen E, Goldberg E, Shochat T, Levi A, Garty M, Krause I. The degree of asymptomatic hyperuricemia and the risk of gout. A retrospective analysis of a large cohort. Clin Rheumatol. 2014;33:549\u201353.","journal-title":"Clin Rheumatol"},{"issue":"3","key":"1697_CR9","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3899\/jrheum.160452","volume":"44","author":"A Shiozawa","year":"2017","unstructured":"Shiozawa A, Szabo SM, Bolzani A, Cheung A, Choi HK. Serum uric acid and the risk of incident and recurrent gout: a systematic review. J Rheumatol. 2017;44(3):388\u201396.","journal-title":"J Rheumatol"},{"issue":"2","key":"1697_CR10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/art.1780150209","volume":"15","author":"JN Loeb","year":"1972","unstructured":"Loeb JN. The influence of temperature on the solubility of monosodium urate. Arthritis Rheum. 1972;15(2):189\u201392.","journal-title":"Arthritis Rheum"},{"key":"1697_CR11","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13075-016-1062-6","volume":"18","author":"M Dehlin","year":"2016","unstructured":"Dehlin M, Drivelegka P, Sigurdardottir V, Sv\u00e4rd A, Jacobsson L. Incidence and prevalence of gout in western Sweden. 2016. Arthritis Res Ther. 2016;18:164.","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"1697_CR12","doi-asserted-by":"publisher","first-page":"e00032","DOI":"10.1136\/rmdopen-2016-000326","volume":"2","author":"MC Kapetanovic","year":"2016","unstructured":"Kapetanovic MC, Adel M, Turkiewicz, Noegi T, Saxne T, Jacobsson L, Englund M. Prevalence and incidence of gout in southern Sweden from the socioeconomic perspective. RMD Open. 2016;2(2):e00032.","journal-title":"RMD Open"},{"issue":"Suppl 2","key":"1697_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1185\/03007995.2015.1087979","volume":"31","author":"RJ Johnson","year":"2015","unstructured":"Johnson RJ. Why focus on uric acid? Curr Med Res Opin. 2015;31(Suppl 2):3\u20137.","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"1697_CR14","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.semarthrit.2016.07.015","volume":"46","author":"L Stamp","year":"2017","unstructured":"Stamp L, Dalbeth N. Urate-lowering therapy for asymptomatic hyperuricaemia: a need for caution. Semin Arthritis Rheum. 2017 Feb;46(4):457\u201364.","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"1697_CR15","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1136\/annrheumdis-2017-212288","volume":"77","author":"N Dalbeth","year":"2018","unstructured":"Dalbeth N, Phipps-Green A, Frampton C, Neogi T, Taylor WJ, Merriman TR. Relationship between serum urate concentration and clinically evident incident gout: an individual participant data analysis. Ann Rheum Dis. 2018 Jul;77(7):1048\u201352.","journal-title":"Ann Rheum Dis"},{"key":"1697_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1046\/j.1365-2796.2000.00568.x","volume":"244","author":"G Berglund","year":"2000","unstructured":"Berglund G, Nilsson P, Nilsson J-A, et al. Long-term outcome of the Malm\u00f6 preventive project. Total mortality and cardiovascular morbidity. J Intern Med. 2000;244:19\u201329.","journal-title":"J Intern Med"},{"issue":"3","key":"1697_CR17","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3109\/00365513.2011.557086","volume":"71","author":"A Grubb","year":"2011","unstructured":"Grubb A, Sterner G, Nyman U. Revised equations for estimating glomerular filtration rate based on the Lund-Malm\u00f6 study cohort. Scand J Clin Lab Invest. 2011;71(3):232\u20139.","journal-title":"Scand J Clin Lab Invest"},{"key":"1697_CR18","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1177\/000456328201900504","volume":"19","author":"G Fex","year":"1982","unstructured":"Fex G, Kristenson H, Trell E. Correlations of serum lipids and lipoproteins with gammaglutamyltransferase and attitude to alcohol consumption. Ann Clin Biochem. 1982;19:345\u20139.","journal-title":"Ann Clin Biochem"},{"key":"1697_CR19","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/0091-7435(83)90248-7","volume":"12","author":"E Trell","year":"1983","unstructured":"Trell E. Community-based preventive medical department for individual risk factor assessment and intervention in an urban population. Prev Med. 1983;12:397\u2013402.","journal-title":"Prev Med"},{"issue":"3","key":"1697_CR20","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1360-0443.1982.tb02459.x","volume":"77","author":"H Kristenson","year":"1982","unstructured":"Kristenson H, Trell E. Indicators of alcohol consumption: comparisons between a questionnaire (mm-MAST), interviews and serum gamma-glutamyl transferase (GGT) in a health survey of middle-aged males. Br J Addict. 1982;77(3):297\u2013304.","journal-title":"Br J Addict"},{"key":"1697_CR21","unstructured":"Statistics Sweden. The Swedish population and housing census (folk- och bostadsr\u00e4kningen) 1965-1990. Available at \n                    https:\/\/www.scb.se\/sv_\/Hitta-statistik\/Historisk-statistik\/Digitaliserat%2D%2D-Statistik-efter-serie\/Sveriges-officiella-statistik-SOS-utg-1912-\/Folk%2D%2Doch-bostadsrakningarna-1860-1990\/\n                    \n                  . Accessed 26 Feb 2018."},{"issue":"4","key":"1697_CR22","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1002\/art.27338","volume":"62","author":"V Bhole","year":"2010","unstructured":"Bhole V, de Vera M, Rahman MM, Krishnan E, Choi H. Epidemiology of gout in women: fifty-two-year follow-up of a prospective cohort. Arthritis Rheum. 2010;62(4):1069\u201376.","journal-title":"Arthritis Rheum"},{"key":"1697_CR23","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s10067-011-1802-6","volume":"31","author":"JH Chen","year":"2012","unstructured":"Chen JH, Yeh WT, Chuang SY, Wu YY, Pan WH. Gender-specific risk factors for incident gout: a prospective cohort study. Clin Rheumatol. 2012;31:239\u201345.","journal-title":"Clin Rheumatol"},{"key":"1697_CR24","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/acr.20344","volume":"63","author":"PC Grayson","year":"2011","unstructured":"Grayson PC, Kim SY, LaValley M, Choi HK. Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2011;63:102\u201310.","journal-title":"Arthritis Care Res (Hoboken)."},{"issue":"6","key":"1697_CR25","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1161\/HYPERTENSIONAHA.116.08998","volume":"69","author":"M Kuwabara","year":"2017","unstructured":"Kuwabara M, Niwa K, Hisatome I, Nakagawa T, Roncal-Jimenez CA, Andres-Hernando A, Bjornstad P, Jensen T, Sato Y, Milagres T, Garcia G, Ohno M, Lanaspa MA, Johnson RJ. Asymptomatic hyperuricemia without comorbidities predicts cardiometabolic diseases: five-year Japanese cohort study. Hypertension. 2017;69(6):1036\u201344.","journal-title":"Hypertension"},{"issue":"4","key":"1697_CR26","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1136\/annrheumdis-2016-209958","volume":"76","author":"C Maglio","year":"2017","unstructured":"Maglio C, Peltonen M, Neovius M, Jacobson P, Jacobsson L, Rudin A, Carlsson LM. Effects of bariatric surgery on gout ins-cidence in the Swedish Obese Subjects study: a non-randomised, prospective, controlled intervention trial. Ann Rheum Dis. 2017;76(4):688\u201393.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1697_CR27","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/ijo.2014.72","volume":"39","author":"LM Carlsson","year":"2015","unstructured":"Carlsson LM, Romeo S, Jacobson P, Burza MA, Maglio C, Sj\u00f6holm K, Svensson PA, Haraldsson B, Peltonen M, Sj\u00f6str\u00f6m L. The incidence of albuminuria after bariatric surgery and usual care in Swedish Obese Subjects (SOS): a prospective controlled intervention trial. Int J Obes. 2015;39(1):169\u201375.","journal-title":"Int J Obes"},{"issue":"4","key":"1697_CR28","doi-asserted-by":"publisher","first-page":"e006843","DOI":"10.1136\/bmjopen-2014-006843","volume":"5","author":"W Wang","year":"2015","unstructured":"Wang W, Bhole VM, Krishnan E. Chronic kidney disease as a risk factor for incident gout among men and women: retrospective cohort study using data from the Framingham heart study. BMJ Open. 2015;5(4):e006843.","journal-title":"BMJ Open"},{"issue":"5","key":"1697_CR29","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/acr.22830","volume":"68","author":"Z Li","year":"2016","unstructured":"Li Z, Meng L, Huang Z, Cui L, Li W, Gao J, Wang Z, Zhang R, Zhou J, Zhang G, Chen S, Zheng X, Cong H, Gao X, Wu S. Ideal cardiovascular health metrics and incident hyperuricemia. Arthritis Care Res (Hoboken). 2016;68(5):660\u20136.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"8","key":"1697_CR30","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nrrheum.2016.102","volume":"12","author":"PC Robinson","year":"2016","unstructured":"Robinson PC, Choi HK, Do R, Merriman TR. Insight into rheumatological cause and effect through the use of Mendelian randomization. Nat Rev Rheumatol. 2016;12(8):486\u201396.","journal-title":"Nat Rev Rheumatol"},{"key":"1697_CR31","doi-asserted-by":"crossref","unstructured":"Johnson RJ, Bakris GL, Borghi C, Chonchol MB, Feldman D, Lanaspa MA, Merriman TR, Moe OW, Mount DB, Sanchez Lozada LG, Stahl E, Weiner DE, Chertow GM. Hyperuricemia, acute and chronic kidney disease, hypertension, and cardiovascular disease: report of Scientific Workshop organized by the National Kidney Foundation. Am J Kidney. 2018;71(6):851\u201365.","DOI":"10.1053\/j.ajkd.2017.12.009"},{"issue":"9417","key":"1697_CR32","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/S0140-6736(04)16000-5","volume":"363","author":"HK Choi","year":"2004","unstructured":"Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Alcohol intake and risk of incident gout in men: a prospective study. Lancet. 2004;363(9417):1277\u201381.","journal-title":"Lancet"},{"key":"1697_CR33","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ypmed.2015.10.003","volume":"81","author":"P Wandell","year":"2015","unstructured":"Wandell P, Carlsson AC, Ljunggren G. Gout and its comorbidities in the total population of Stockholm. Prev Med. 2015;81:387\u201391.","journal-title":"Prev Med"},{"key":"1697_CR34","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/1471-2369-15-122","volume":"15","author":"L Li","year":"2014","unstructured":"Li L, Yang C, Zhao Y, Zeng X, Liu F, Fu P. Is hyperuricemia an independent risk factor for new-onset chronic kidney disease? A systematic review and meta-analysis based on observational cohort studies. BMC Nephrol. 2014;15:122. \n                    https:\/\/doi.org\/10.1186\/1471-2369-15-122\n                    \n                  .","journal-title":"BMC Nephrol"},{"issue":"2","key":"1697_CR35","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1053\/j.ajkd.2017.01.053","volume":"70","author":"S Kim","year":"2017","unstructured":"Kim S, Chang Y, Yun KE, Jung HS, Lee SJ, Shin H, Ryu S. Development of nephrolithiasis in asymptomatic hyperuricemia: a cohort study. Am J Kidney Dis. 2017;70(2):173\u201381.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"1697_CR36","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13075-017-1376-z","volume":"19","author":"AJ Landgren","year":"2017","unstructured":"Landgren AJ, Jacobsson LTH, Lindstr\u00f6m U, Sandstr\u00f6m TZS, Drivelegka P, Bj\u00f6rkman L, Fjellstedt E, Dehlin M. Incidence of and risk factors for nephrolithiasis in patients with gout and the general population, a cohort study. Arthritis Res Ther. 2017;19(1):173.","journal-title":"Arthritis Res Ther."},{"issue":"1","key":"1697_CR37","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/jcp.25855","volume":"233","author":"G Maurizi","year":"2018","unstructured":"Maurizi G, Della Guardia L, Maurizi A, Poloni A. Adipocytes properties and crosstalk with immune system in obesity-related inflammation. Cell Physiol. 2018;233(1):88\u201397.","journal-title":"Cell Physiol"},{"issue":"5","key":"1697_CR38","doi-asserted-by":"publisher","first-page":"e19901","DOI":"10.1371\/journal.pone.0019901","volume":"6","author":"T Lyngdoh","year":"2011","unstructured":"Lyngdoh T, Marques-Vidal P, Paccaud F, Preisig M, Waeber G, Bochud M, Vollenweider P. Elevated serum uric acid is associated with high circulating inflammatory cytokines in the population-based Colaus study. PLoS One. 2011;6(5):e19901.","journal-title":"PLoS One"},{"key":"1697_CR39","doi-asserted-by":"crossref","unstructured":"Kono H, Chen CJ, Ontiveros F, Rock KL. Uric acid promotes an acute inflammatory response to sterile cell death in mice. J Clin Invest. 2010;120(6):1939\u201349.","DOI":"10.1172\/JCI40124"},{"issue":"2","key":"1697_CR40","doi-asserted-by":"publisher","first-page":"e000157","DOI":"10.1161\/JAHA.113.000157","volume":"3","author":"E Krishnan","year":"2014","unstructured":"Krishnan E. Interaction of inflammation, hyperuricemia, and the prevalence of hypertension among adults free of metabolic syndrome: NHANES 2009-2010. J Am Heart Assoc. 2014;3(2):e000157.","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"1697_CR41","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s40471-017-0128-6","volume":"4","author":"J Zheng","year":"2017","unstructured":"Zheng J, Baird D, Borges MC, Bowden J, Hemani G, Haycock P, Evans DM, Smith GD. Recent developments in Mendelian randomization studies. Curr Epidemiol Rep. 2017;4(4):330\u201345.","journal-title":"Curr Epidemiol Rep"},{"issue":"1","key":"1697_CR42","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13075-016-1211-y","volume":"19","author":"M Dehlin","year":"2017","unstructured":"Dehlin M, Ekstr\u00f6m EH, Petzold M, Str\u00f6mberg U, Telg G, Jacobsson LT. Factors associated with initiation and persistence of urate-lowering therapy. Arthritis Res Ther. 2017;19(1):6.","journal-title":"Arthritis Res Ther"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1697-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-018-1697-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1697-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T03:14:50Z","timestamp":1569381290000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-018-1697-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,29]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1697"],"URL":"https:\/\/doi.org\/10.1186\/s13075-018-1697-6","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,29]]},"assertion":[{"value":"5 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The ethical approval was obtained from the Regional Ethics Committee at Lund University (Dnr 85\/2004).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"190"}}